A team including leading lung cancer researchers, and CollabRx scientists, has just published a novel Lung Cancer Molecular Disease Model in PLoS ONE, a leading peer-reviewed open source journal. (click here to read the published paper online). This is the model that underlies the CollabRx Lung Cancer Targeted Therapy Finder App.
Previous Entry: Targeted Therapies Improve Prognosis for Lung Cancer Patients
Next Entry: UK: GPs to prescribe health apps